Pilot Surveillance of Babesia, Borrelia burgdorferi, and Anaplasma phagocytophilum Among Chinese Blood Donors - Xinjiang, Inner Mongolia, and Heilongjiang PLADs, China, 2022-2023.

IF 4.3 Q1 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH

中国疾病预防控制中心周报 Pub Date : 2024-11-15 DOI:10.46234/ccdcw2024.243

Huimin Ji, Le Chang, Ying Yan, Huizhen Sun, Lunan Wang

{"title":"Pilot Surveillance of Babesia, Borrelia burgdorferi, and Anaplasma phagocytophilum Among Chinese Blood Donors - Xinjiang, Inner Mongolia, and Heilongjiang PLADs, China, 2022-2023.","authors":"Huimin Ji, Le Chang, Ying Yan, Huizhen Sun, Lunan Wang","doi":"10.46234/ccdcw2024.243","DOIUrl":null,"url":null,"abstract":"What is already known about this topic?: Recently, tick-borne pathogens transmitted through blood transfusions have posed new risks to blood safety.What is added by this report?: We developed a quality control system for nucleic acid testing (NAT) for Babesia, Borrelia burgdorferi, and Anaplasma phagocytophilum, evaluated five Triplex-NAT kits, and conducted external quality assessments of blood centers. This study screened 92,700 blood donors from Heilongjiang, Inner Mongolia, and Xinjiang provincial-level administrative divisions during 2022-2023. A donor in Hegang, Heilongjiang, tested positive for Borrelia burgdorferi, marking the first detection of this infection in Chinese blood donors.What are the implications for public health practice?: Quality control of NAT is vital for managing tick-borne pathogen outbreaks. To ensure blood transfusion safety, screening should be strengthened in high-risk areas outside national borders.","PeriodicalId":69039,"journal":{"name":"中国疾病预防控制中心周报","volume":"6 46","pages":"1206-1210"},"PeriodicalIF":4.3000,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11581989/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国疾病预防控制中心周报","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.46234/ccdcw2024.243","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}

引用次数: 0

Abstract

What is already known about this topic?: Recently, tick-borne pathogens transmitted through blood transfusions have posed new risks to blood safety.

What is added by this report?: We developed a quality control system for nucleic acid testing (NAT) for Babesia, Borrelia burgdorferi, and Anaplasma phagocytophilum, evaluated five Triplex-NAT kits, and conducted external quality assessments of blood centers. This study screened 92,700 blood donors from Heilongjiang, Inner Mongolia, and Xinjiang provincial-level administrative divisions during 2022-2023. A donor in Hegang, Heilongjiang, tested positive for Borrelia burgdorferi, marking the first detection of this infection in Chinese blood donors.

What are the implications for public health practice?: Quality control of NAT is vital for managing tick-borne pathogen outbreaks. To ensure blood transfusion safety, screening should be strengthened in high-risk areas outside national borders.

查看原文本刊更多论文

中国献血者中巴贝斯虫、鲍氏包虫和噬细胞无形体的试点监测 - 中国新疆、内蒙古和黑龙江 PLADs，2022-2023 年。

本专题的已知信息最近，通过输血传播的蜱媒病原体给血液安全带来了新的风险：我们开发了一套针对巴贝西亚原虫、布氏杆菌和噬血疟原虫的核酸检测（NAT）质量控制系统，评估了五种 Triplex-NAT 试剂盒，并对血液中心进行了外部质量评估。这项研究在 2022-2023 年期间对黑龙江、内蒙古和新疆省级行政区的 92700 名献血者进行了筛查。黑龙江鹤岗市一名献血者的博氏包柔氏菌检测结果呈阳性，这是中国献血者中首次发现博氏包柔氏菌感染：NAT 的质量控制对于控制蜱传病原体的爆发至关重要。为确保输血安全，应在境外高风险地区加强筛查。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国疾病预防控制中心周报

CiteScore

5.90

自引率

0.00%

发文量